Immunogenicity and safety of high-dose hepatitis B vaccine among drug users: A randomized, open-labeled, blank-controlled trial

• Main Authors: Yongliang Feng (Author), Jing Shi (Author), Linying Gao (Author), Tian Yao (Author), Dan Feng (Author), Dan Luo (Author), Zhansheng Li (Author), Yawei Zhang (Author), Fuzhen Wang (Author), Fuqiang Cui (Author), Li Li (Author), Xiaofeng Liang (Author), Suping Wang (Author)
• Format: Book
• Published: Taylor & Francis Group, 2017-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Due to the low uptake, adherence, and completion of vaccination among drug users, and their compromised immune responses to hepatitis B vaccination, the current practice of hepatitis B vaccination may not provide optimal protection. The aim of this study was to evaluate the immunogenicity and safety...